Works matching IS 00099104 AND DT 2020 AND VI 202 AND IP 1
Results: 11
Combination of pegylated interferon‐alpha and nucleos(t)ide analogue treatment enhances the activity of natural killer cells in nucleos(t)ide analogue experienced chronic hepatitis B patients.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 1, p. 80, doi. 10.1111/cei.13486
- By:
- Publication type:
- Article
Activated inducible co‐stimulator‐positive programmed cell death 1‐positive follicular helper T cells indicate disease activity and severity in ulcerative colitis patients.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 1, p. 106, doi. 10.1111/cei.13485
- By:
- Publication type:
- Article
TREC and KREC profiling as a representative of thymus and bone marrow output in patients with various inborn errors of immunity.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 1, p. 60, doi. 10.1111/cei.13484
- By:
- Publication type:
- Article
Neutrophil elastase and endogenous inhibitors in Behçet's disease saliva.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 1, p. 93, doi. 10.1111/cei.13483
- By:
- Publication type:
- Article
Leonurus sibiricus root extracts decrease airway remodeling markers expression in fibroblasts.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 1, p. 28, doi. 10.1111/cei.13481
- By:
- Publication type:
- Article
Heparin affects the induction of regulatory T cells independent of anti‐coagulant activity and suppresses allogeneic immune responses.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 1, p. 119, doi. 10.1111/cei.13480
- By:
- Publication type:
- Article
Engineering of chimeric natural killer cell receptors to develop precision adoptive immunotherapies for cancer.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 1, p. 11, doi. 10.1111/cei.13478
- By:
- Publication type:
- Article
Suppressor of cytokine signaling 1 inhibits the maturation of dendritic cells involving the nuclear factor kappa B signaling pathway in the glioma microenvironment.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 1, p. 47, doi. 10.1111/cei.13476
- By:
- Publication type:
- Article
Abnormal processing of IL‐1β in NLRP7‐mutated monocytes in hydatidiform mole patients.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 1, p. 72, doi. 10.1111/cei.13472
- By:
- Publication type:
- Article
Pathological role of excessive DNA as a trigger of keratinocyte proliferation in psoriasis.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 1, p. 1, doi. 10.1111/cei.13455
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical & Experimental Immunology, 2020, v. 202, n. 1, p. 1, doi. 10.1111/cei.13326
- Publication type:
- Article